In a major boost to Pakistan’s pharmaceutical sector, BF Biosciences Limited has introduced Zeptide (Tirzepatide), an advanced dual-action therapy for Type 2 diabetes and obesity, developed and manufactured at its local facility. The pharma shared the development in its notice to the Pakistan Stock Exchange (PSX) on Tuesday. Tirzepatide, approved by the US Food and Drug Administration (FDA),